Full Name
Ira Klein, MD
Job Title
VP Medical Affairs Payor Relations
Company
Access to Comprehensive Genomic Profiling (ACGP)
Speaker Bio
Dr. Ira Klein is the vice president of medical affairs for payor relations for Tempus Labs, managing for the past four years in payer policy and payment, revenue cycle management, market access, and technology based solutions.
Previously, he was the chief medical officer of health New England, covering MA, commercial, and Medicaid products. Before that, he led healthcare quality strategy across all Janssen brands for J&J Health Care Services for five years. Prior to that, in his 10 years at Aetna, he was the national medical director for clinical thought leadership, chief of staff to the CMO, and founded the Oncology Solutions team.
His early career included assistant CMO of Bayshore Community Health System, CMO of Elderplan, and assistant professor medicine at RWJMS for seven years. Dr. Klein is widely published in multiple journals, including Journal of Oncology Practice, Journal of Clinical Oncology, American Journal of Managed Care, and Journal of Clinical Pathways. He is an AOA graduate of RWJMS, residency at Brown University and RWJMS, also MBA from Rutgers School of Business and undergraduate at Rutgers College of Pharmacy, both with highest honors. Professional interests include health information technology and artificial intelligence, operations management, and pharmacoeconomics.
Previously, he was the chief medical officer of health New England, covering MA, commercial, and Medicaid products. Before that, he led healthcare quality strategy across all Janssen brands for J&J Health Care Services for five years. Prior to that, in his 10 years at Aetna, he was the national medical director for clinical thought leadership, chief of staff to the CMO, and founded the Oncology Solutions team.
His early career included assistant CMO of Bayshore Community Health System, CMO of Elderplan, and assistant professor medicine at RWJMS for seven years. Dr. Klein is widely published in multiple journals, including Journal of Oncology Practice, Journal of Clinical Oncology, American Journal of Managed Care, and Journal of Clinical Pathways. He is an AOA graduate of RWJMS, residency at Brown University and RWJMS, also MBA from Rutgers School of Business and undergraduate at Rutgers College of Pharmacy, both with highest honors. Professional interests include health information technology and artificial intelligence, operations management, and pharmacoeconomics.
Speaking At

